Biblio Discovery — Demo Discovery Service

8 hasil untuk "Anmol Baranwal"

Menampilkan 1–8 · 0,59 detik · RSS

  1. Artikel Jurnal

    Tumor Lysis Syndrome in a Patient With Gastric Adenocarcinoma

    Prasanth Lingamaneni MD; Parth Desai MD; Madhu Mathew Vennikandam MD dkk.

    Journal of Investigative Medicine High Impact Case Reports, Vol. 8 · 2020 · Inggris · DOAJ Scopus

    Tumor lysis syndrome (TLS) is a severe metabolic complication that usually occurs in patients with aggressive tumors who undergo treatment with chemotherapy. Traditionally, it was mainly associated with hematologic malignancies. However, over the past 4 decades, there have been increasing reports…

  2. Artikel Jurnal Teks lengkap

    Genetic landscape and clinical outcomes of patients with BCOR mutated myeloid neoplasms

    Anmol Baranwal; Mark Gurney; Rami Basmaci dkk.

    Haematologica, Vol. 109 No. 6 · 2024 · Inggris · DOAJ Scopus

    The BCL6-corepressor (BCOR) is a tumor-suppressor gene located on the short arm of chromosome X. Data are limited regarding factors predicting survival in BCOR-mutated (mBCOR) acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). We evaluated 138 patients with mBCOR myeloid disorders, of…

    Juga tersedia di: DOAJ

  3. Artikel Jurnal

    TP53 mutation variant allele frequency of ≥10% is associated with poor prognosis in therapy-related myeloid neoplasms

    Mithun Vinod Shah; Elizabeth Ngoc Hoa Tran; Syed Shah dkk.

    Blood Cancer Journal, Vol. 13 No. 1 · 2023 · Inggris · DOAJ Scopus

    Abstract Revised diagnostic criteria for myeloid neoplasms (MN) issued by the International Consensus Classification (ICC) and the World Health Organization (WHO) recommended major change pertaining to TP53-mutated (TP53 mut) MN. However, these assertions have not been specifically examined in…

  4. Artikel Jurnal

    Factors associated with survival after allogeneic transplantation for myeloid neoplasms harboring TP53 mutations

    Anmol Baranwal; Kimberly J. Langer; Vedavyas Gannamani dkk.

    Blood Advances, Vol. 9 No. 14 · 2025 · Inggris · DOAJ Scopus

    Abstract: Allogeneic hematopoietic stem cell transplant (alloHCT) is considered for all patients with myeloid neoplasms (MNs) harboring TP53 mutations (TP53mut). The aim of this international study across 7 transplant centers in the United States and Australia was to identify factors associated…

  5. Artikel Jurnal

    Validation of the 5th edition of the World Health Organization and International Consensus Classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohort

    Mithun Vinod Shah; Kevin Hung; Anmol Baranwal dkk.

    Blood Cancer Journal, Vol. 15 No. 1 · 2025 · Inggris · DOAJ Scopus

    Abstract The World Health Organization (WHO-5) and International Consensus Classification (ICC) acknowledge the poor prognosis of TP53-mutated (TP53 mut) myeloid neoplasm (MN). However, there are substantial differences between the two classifications that may lead to under- or overestimation of…